Specific Induction of Metallothionein in Hairless Mouse Skin by Zinc and Dexamethasone  by Mullin, Catherine H. et al.
Specific Induction of Metallothionein in Hairless 
Mouse Skin by Zinc and Dexalllethasone 
Catherine H. Mullin, B.A., C;udrun Frings, B.S., Josef Abel, D .V.M., Peter Paul Kind, M.D. , and 
Gi.inther Goerz, M .D . 
Depa rtment of T ox icology. Medical Institute of Environmental Hygiene (C HM , jA), D Li sse ldo rf, and C lini c of Dermatology , 
University o f Dusseldorf (GF, PPK , GG) , DLisscidorf, F. R. G. 
The stimulation of metallothionein (MT) synthesis in mouse 
skin after i. p . trea tments with various doses of dexa meth-
asone o r zinc was demonstrated. Specific MT mRNA in-
duction was determined by Northern analysis. Zinc was a 
mo re effi cient inducer th an dexamethasone. The maximal 
M etallothioneills (MT) are metal binding proteins that are w idely distributed in mammals, inver-tebrates, plants, and microorganisms [1]. The essenti al fea tures th at distin guish these proteins include the presence of metal clusters with bridg-
ing li gands, inducibility, high cysteine content, and a lack of 
aromatic amino acids [2] . M etallothioneins possess stron g affin-
ities for Zn, C d, H g, Ag , and C u. T he inducibility of the MT 
genes by these meta ls has been demonstrated in vivo, especiall y 
in liver and kidney [3]. Furthermore, MT is also transcriptiona ll y 
controlled by glucocorticoids , gamma interferon, Iipopolysac-
charides, and interleukin 1 [4-7] . Although much is known about 
MT, its exact physiologic fun ction remains to be elucidated. 
Z in c and steroids are therapeuti ca ll y used in various derma-
tologic di seases. Instead of topica l application , glucoco rticoids 
are, in some cases, systemica ll y ad ministered . Therefore, in this 
preliminary study we show an increased MT mRNA accumu-
lation and MT synthesis in mouse skin after i. p. administration 
of zinc o r dexamethasone. 
MATE RIALS AND METHODS 
Preparation of Skin Samples H airless female mice (HR/ HR 
Henkel), kind ly provided by Henkel Gm bH , Dusseldorf, were 
used in this stud y. Zi nc sulfate and dexa methasone (Fortecortin, 
Merck, Darmstadt, F.R.G.) were injected i. p. at the concentra-
tions indica ted below. The mice were sacrificed and skinn ed at 
different times (see below) . Six-millimeter punch biopsies were 
taken from the back and scraped to remove fat and lower dermis. 
A typica l specimen is shown in Fig 1 (H & E stained) . 
Determination of Metallothionein For MT measurements 
the skin samples were first homogenized for 30 s with an Ultra-
Turrax followed by 10 strokes with a Potter-Elverhj em in 50 mM 
Tris, 100 mM NaC I, pH 8.4. The homogenate was th en centri-
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Abbreviations: 
bw: body weight 
MT: meta llo thionein 
wwt: wet weight 
MT accumul ation occurs after i. p. inj ections of50-1 00 mg 
dexam ethasone/kg body w eight. The possible role of MT 
in the skin is briefly discussed . J In vest Derl1lllto/ 89:164-
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fu ged for 5 min in an Eppendorf centrifuge . The MT was qu an-
tified using the C d-saturati on assay [8]. 
Northern Blot Analysis of MT mRNA For N orthern blot 
analysis tota l nucleic acids were iso lated from sim ilarly prepared 
sa mples as described prev iously [91. Ribonucleic acid was then 
purified by centrifu ga ti on on CsCI [10]. T en microg rams of to tal 
RNA /ex periment was denatured in 50% fo rm amide-6. 5% form-
aldehyde. T hese samples were then el ectrophoresed on a hori-
zontal fo rm aldehyde aga rose gel (1.5% agarose, 6.5% form al-
dehyde) in RNA runnin g buffer (40 mM MOPS). Separated RNA 
was transfered to Gene Screen Plus membrane allowing for sub-
sequ ent MT mRNA sequences detecti on using a plasmid con-
tainin g the mouse MT -1 gene (generously donated by Dr. R. 
Palmi ter. Seattle, Washington). The probe was radioactively la-
beled w ith 32p using a nick trans lation kit (Amersham, Braun-
schweig). All furth er hybridi za tion steps were performed as de-
scribed by Maniatis et al \11] . Visualiza tion o f MT mRNA was 
don e by auto radiogra ph y aft'er ex posure to x-ray film (D upont) 
fo r 48 h using Dupont Lightnin g Plus intensifying screens. 
RESULTS 
T he time course of the MT concentrations in mouse skin after a 
single i. p. inj ection with 50 m g dexa meth asone/kg body weight 
(bw) is shown in Fig 2. In untrea ted mice (N = 31) the MT 
content in the skin was 1.08 ± 0.18 pmollmg wet weight (wwt). 
After 12 h of dexa melhasone trea tment the MT concentration 
was eleva ted by a maximum factor of2.5 (Fig 2) . Thereafter the 
concentration leveled off (18 h) and return ed to contro l va lues by 
48 h. Figure 3 shows the res ults of the Northern blot experiment, 
in which th e anima ls were treated with th e same dose of dexa-
methasone o r 10 mg Zn " + /kg bw. A significant increase of MT 
mRN A was seen after 4 and 24 h when compared w ith th e control 
group . The increase due to Zn + + was more prominent than th at 
due to dexameth asone. Also by 24 h the induction caused by 
dexamethasone decreased , approaching basal levels, whereas ac-
cumulati on du e to Zn + + continued. The dose response for hor-
mone (Fig 4) was conducted at 18 h and showed a maximum MT 
accumulation at doses between 50-100 m g dexamethasone/ kg 
bw. T able I indi ca tes the va lues for Zn + + dose response at 18 h . 
This meta l dose dependently elevated the MT content of the skin . 
The maximal va lue (3.6 pmol MT/ m g wwt) was found after 
inj ection of 10 m g Zn + + / kg bw (Table I). 
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Figure 1. A typical specimen (H & E-s tai ned) of mousc skin which was 
used for preparation of RNA or quanti fica tion of MT. 
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Figure 2. Time course showing MT accumulation in the mouse skin 
after a sin gle i. p. inj ection of 50 mg dexa methasone (opm cirdcs) / kg bw. 
Solid circles = control. 
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Figure 3. Northern blot analys is of MT mR N A in the mouse skin aftc r 
single i. p. inj ection of 10 mg Zn + + /kg or 50 mg dexa mcthasone/ kg bw. 
Total RNA was prepared 4 and 24 h after ad ministration. Ten micrograms 
per lane of total RNA was electrophresed. Conrrollancs: (1) 4 h Zn; (2) 
4 h dexa meth asone; (3) 4 h control; (4) 24 h control; (5) 24 h Zn; (6) 24 
h dexamethasone. 
DISC USSI O N 
In this study we dem onstrate that MT is specifi ca ll y induced b y 
dexa m ethasone and zin c in m o use skin. The M T mRNA accu-
mulatio n begins as ea rl y as 4 h fo llowin g inj ectio n o f eith er in-
du cer althou gh the gene is m o re res po nsive to zin c than to dex-
am eth asone. The am ount of M T mRNA present in the skin of 
zin c-trea ted animals is nea rl y d ouble that seen after dexa m etha-
sone trea tment. This is quite similar to wh at is fo und in o ther 
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Figure 4. Dose responsc curve of MT accuillul ation in the mouse skin 
18 h after i. p. injections with va rious dexamethasone concentrations. 
sys tem s [12]. T he m aximum MT synthesis was seen afte r 12 h 
of dexa m cthasone trea tm en t w hich fo llows the in crease in MT 
mRN A. In o th er o rgan s such as li ve r and kidney, pro tein syn-
th esis pea ks 6-8 h fo llowin g th e m axi mum accuIl1ulatio n of MT 
mRNA [4, 13.1. Altho ugh o ur experimen ta l d esign ca nno t exactly 
identi fy in w hich cell types M T was induced , it has recentl y been 
shovv n th at M T is present in cul tured primar y hum an keratino-
cy tes (H . Kappus and K . H . Summer, personal communicatio n) 
and fibro blast cell lin es 11 4]. 
It is kn own that zin c and dexa m eth asone ca n independentl y 
regulate MT expressio n b y stimulatin g di fferent region s of the 
MT gene [15] and that the inductio n of M T synthesis b y dexa-
l1I eth asone is acco mpanied by in cre3sed intracellul ar zinc uptake 
[1 6 ]. Z in c is an essential elem ent and is impo rtant fo r m an y en-
zy m atic reactio ns 116]. Altho ug h the exact ph ysio logic fun ctio n 
of zin c in the epidermis is no t kn own , it is in creasin g ly bclieved 
th at it is in volved in the process of keratini za tio n [1 7]. Zin c de-
fic iency in animals is o ften acco mpanied by de rm ato logic alter-
ati ons. In zin c-defi cient ra ts cystein e in co rpo ration in epiderm al 
pro teins W3S decreased 11 81. The redu ced fo rm of this am ino acid 
is an esscntial (30%) compo ncnt o f M T. In hum ans, acroder-
m atitis ente ro pathi ca is the pro to ty pe o f a skin disease caused by 
zin c defi cien cy. Z in c abnorm alities have also been pos tulated fo r 
pustular psori as is [1 9]. G lu coco rti co ids are o ften used in trea tin g 
sk in d iseases . Topicall y 3ppli ca ted g lucocorticoids can reverse 
abno rm al epidermal diffe rentiation [20] and h yperproliferatio n 
[21], and redu ce derm al inflammato ry cell infiltrate and vasodi-
lation in pati ents w ith d iseases such as pso ri as is . This ho rm one, 
fo r w hich recepto rs have been fo und in the dermis as well as the 
epide rmis [22], also induces a -type keratini za tio n [231. O n e pos-
sible ex planatio n fo r the bene fi cial effect of zinc and g lucocorticoid 
ho rm ones in so m e skin d iseases m ay be due to an in creased cellul ar 
zinc content in w hi ch M T plays an integral part. 
Table I. Accumulation of M eta llo thio nein (M T) 
Number MT Content 
Dose Zinc of An imals (pmollmg wwt) 
0.0 31 1.08±0. IS 
5.0 6 1. 75 ± 0. !3 
10.0 22 3.6 ± 0.98 
Accu iU I113tiOll of MT in the m ouse sk in after single i. p. injections of 5 o r 
10 mg Z n ++/kg bw. T he MT was quanti fIed 18 h after zinc ad m inistrati on 
(va lues arc exp ressed as x ± Sx). 
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